ACM
TCON

ACT Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

ACT Capital Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$48K Hold
1,425
– – 0.07% 56
2022
Q2 		$57K Hold
1,425
– – 0.08% 59
2022
Q1 		$75K Hold
1,425
– – 0.08% 71
2021
Q4 		$79K Hold
1,425
– – 0.06% 83
2021
Q3 		$110K Hold
1,425
– – 0.06% 90
2021
Q2 		$185K Buy
+1,425
New +$197K 0.1% 87

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

ACT Capital Management's TCON Position: Q3 2022 in Review

ACT Capital Management held its TRACON Pharmaceuticals, Inc. Common Stock (TCON) position steady in Q3 2022 at 1,425 shares worth $48K. The position accounts for 0.07% of the portfolio, ranked #56.

ACT Capital Management first reported a position in TCON in Q2 2021 and has held it in 6 quarters since. The position peaked at $185K in Q2 2021. 33 funds tracked by Wall St. Rank hold TCON as of Q3 2022.

  • ACT Capital Management held 1,425 shares of TRACON Pharmaceuticals, Inc. Common Stock worth $48K as of Q3 2022.
  • ACT Capital Management left its TRACON Pharmaceuticals, Inc. Common Stock share count unchanged in Q3 2022.
  • TRACON Pharmaceuticals, Inc. Common Stock made up 0.07% of ACT Capital Management's portfolio in Q3 2022, its #56 holding.
  • ACT Capital Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2021 and has held it in 6 quarters since.
  • ACT Capital Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $185K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.